CastleKnight Management’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-66,700
Closed -$124K 286
2022
Q2
$124K Hold
66,700
0.02% 229
2022
Q1
$238K Buy
66,700
+43,900
+193% +$216K 0.03% 228
2021
Q4
$196K Buy
+22,800
New +$145K 0.04% 168

Other funds holding LHDX

CastleKnight Management's LHDX Position: Q3 2022 in Review

CastleKnight Management sold out of Lucira Health, Inc. Common Stock (LHDX) in Q3 2022, closing a stake of 66,700 shares — an estimated $124K sold.

CastleKnight Management first reported a position in LHDX in Q4 2021 and held it in 3 quarters. The position peaked at $238K in Q1 2022. 28 funds tracked by Wall St. Rank hold LHDX as of Q3 2022.

  • CastleKnight Management reported no remaining Lucira Health, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • CastleKnight Management sold 66,700 Lucira Health, Inc. Common Stock shares in Q3 2022, an estimated $124K.
  • CastleKnight Management first reported a position in Lucira Health, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • CastleKnight Management's Lucira Health, Inc. Common Stock position peaked at $238K in Q1 2022.
  • 28 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q3 2022.

Based on CastleKnight Management's 13F filing for Q3 2022, filed 14 Nov 2022.